Genetic alterations, primarily affecting the mitogen-activated protein kinase (MAPK) signaling pathway, have been identified in melanoma, majority of which is clustered on gain-of-function mutations in BRAF, a cell-signaling molecule that regulates the MAPK pathway [2]. Here, BRAF is linked to melanoma.